Stock Report

Dr. Reddy's Laboratories Ltd reports Rs. 1255.3 crores consolidated PAT in Q2 FY2025



Posted On : 2024-11-05 17:00:15( TIMEZONE : IST )

Dr. Reddy's Laboratories Ltd reports Rs. 1255.3 crores consolidated PAT in Q2 FY2025

has reported Consolidated financial results for the period ended September 30, 2024.

Financial Results (Q2 FY2025) - QoQ Comparison

The company has reported total income of Rs. 8016.2 crores during the period ended September 30, 2024 as compared to Rs. 7672.7 crores during the period ended June 30, 2024.

The company has posted net profit / (loss) of Rs. 1255.3 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs. 1392 crores for the period ended June 30, 2024.

The company has reported EPS of Rs. 15.05 for the period ended September 30, 2024 as compared to Rs. 16.70 for the period ended June 30, 2024.

Financials Q2 FY2025 Q1 FY2025 % Change
Total Income ₹8016.2 crs ₹7672.7 crs Up Tick / Down Tick4.48%
Net Profit ₹1255.3 crs ₹1392 crs Up Tick / Down Tick-9.82%
EPS ₹15.05 ₹16.70 Up Tick / Down Tick-9.88%

Financial Results (Q2 FY2025) - YoY Comparison

The company has reported total income of Rs.8016.2 crores during the period ended September 30, 2024 as compared to Rs.6880.2 crores during the period ended September 30, 2023.

The company has posted net profit / (loss) of Rs.1255.3 crores for the period ended September 30, 2024 as against net profit / (loss) of Rs.1480 crores for the period ended September 30, 2023.

The company has reported EPS of Rs.15.05 for the period ended September 30, 2024 as compared to Rs.17.76 for the period ended September 30, 2023.

Financials Q2 FY2025 Q2 FY2024 % Change
Total Income ₹8016.2 crs ₹6880.2 crs Up Tick / Down Tick16.51%
Net Profit ₹1255.3 crs ₹1480 crs Up Tick / Down Tick-15.18%
EPS ₹15.05 ₹17.76 Up Tick / Down Tick-15.26%

Financial Results (Half Year Ended FY2025) - YoY Comparison

The company has reported total income of Rs.15688.9 crores during the 6 Months period ended September 30, 2024 as compared to Rs.13618.6 crores during the 6 Months period ended September 30, 2023.

The company has posted net profit / (loss) of Rs.2647.3 crores for the 6 Months period ended September 30, 2024 as against net profit / (loss) of Rs.2882.5 crores for the 6 Months period ended September 30, 2023.

The company has reported EPS of Rs.31.74 for the 6 Months period ended September 30, 2024 as compared to Rs.34.60 for the 6 Months period ended September 30, 2023.

Financials Half Year Ended FY2025 Half Year Ended FY2024 % Change
Total Income ₹15688.9 crs ₹13618.6 crs Up Tick / Down Tick15.20%
Net Profit ₹2647.3 crs ₹2882.5 crs Up Tick / Down Tick-8.16%
EPS ₹31.74 ₹34.60 Up Tick / Down Tick-8.27%

Source : Equity Bulls

Keywords

DrReddysLaboratories Q2FY25 H1FY25 Q2FY2025 H1FY2025 ResultUpdate